Medicare Enrolled

Dr. Angel Bayas, MD

Dermatology · Boca Raton, FL
875 MEADOWS RD STE 323, Boca Raton, FL 33486
5617887545
Registered in NPPES since 2020
NPI: 1215565932 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bayas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bayas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bayas

Dr. Angel Bayas is a dermatology specialist in Boca Raton, FL, with 6 years of NPI registration.

Between the years covered by Open Payments, Dr. Bayas received a total of $12,641 from 53 pharmaceutical and/or device companies across 370 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bayas is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years of NPI registration $12,641 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 162127 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$12,641
Total received (2021-2024)
Avg $3,160/year across 4 years
Top 2% in FL for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
370
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,095
2023
$3,743
2022
$528
2021
$1,275

Payments by company (2024)

ABBVIE INC.
$772
MDD US Operations, LLC
$650
ARGENX US, INC.
$501
UCB, Inc.
$474
Alexion Pharmaceuticals, Inc.
$428
Merz Pharmaceuticals, LLC
$422
Eisai Inc.
$395
Neurocrine Biosciences, Inc.
$322
SCILEX PHARMACEUTICALS INC.
$319
EMD Serono, Inc.
$277
Lilly USA, LLC
$271
Takeda Pharmaceuticals U.S.A., Inc.
$247
PFIZER INC.
$188
Biogen, Inc.
$181
Abbott Laboratories
$164
Neurelis, Inc.
$154
Teva Pharmaceuticals USA, Inc.
$140
LivaNova USA, Inc.
$140
ACADIA Pharmaceuticals Inc
$137
Kyowa Kirin, Inc.
$117
MITSUBISHI TANABE PHARMA AMERICA, INC.
$103
Genentech USA, Inc.
$92
Lundbeck LLC
$71
Amneal Pharmaceuticals LLC
$68
Alnylam Pharmaceuticals Inc.
$68
CATALYST PHARMACEUTICALS, INC.
$67
Harmony Biosciences Llc
$50
JAZZ PHARMACEUTICALS INC.
$46
GENZYME CORPORATION
$45
Boston Scientific Corporation
$31
REVANCE THERAPEUTICS, INC.
$30
Octapharma USA, Inc.
$25
CSL Behring
$24
TG Therapeutics, Inc.
$22
Acorda Therapeutics, Inc
$20
Otsuka America Pharmaceutical, Inc.
$18
SERVIER PHARMACEUTICALS LLC
$15
Top 3 companies account for 27.1% of 2024 payments
All-time payments by company (2021-2024) ›
EMD Serono, Inc.
$1,337
ABBVIE INC.
$871
ARGENX US, INC.
$782
Biohaven Pharmaceuticals, Inc.
$744
UCB, Inc.
$713
Alexion Pharmaceuticals, Inc.
$696
MDD US Operations, LLC
$650
AbbVie Inc.
$640
Merz Pharmaceuticals, LLC
$531
Abbott Laboratories
$456
Lilly USA, LLC
$449
Eisai Inc.
$395
Takeda Pharmaceuticals U.S.A., Inc.
$340
Neurocrine Biosciences, Inc.
$322
SCILEX PHARMACEUTICALS INC.
$319
LivaNova USA, Inc.
$282
Neurelis, Inc.
$273
PFIZER INC.
$188
Otsuka America Pharmaceutical, Inc.
$186
Biogen, Inc.
$181
Biohaven Pharmaceutical Holding Company Ltd.
$174
Teva Pharmaceuticals USA, Inc.
$172
GENZYME CORPORATION
$169
Kyowa Kirin, Inc.
$144
ACADIA Pharmaceuticals Inc
$137
MITSUBISHI TANABE PHARMA AMERICA, INC.
$129
E.R. Squibb & Sons, L.L.C.
$125
Horizon Therapeutics plc
$124
Alnylam Pharmaceuticals Inc.
$103
Amneal Pharmaceuticals LLC
$98
Genentech USA, Inc.
$92
Lundbeck LLC
$71
CATALYST PHARMACEUTICALS, INC.
$67
JAZZ PHARMACEUTICALS INC.
$64
CSL Behring
$58
Harmony Biosciences Llc
$50
Harmony Biosciences LLC
$48
Acorda Therapeutics, Inc
$46
Corium, LLC
$42
Octapharma USA, Inc.
$39
AstraZeneca Pharmaceuticals LP
$38
SK Life Science, Inc.
$34
Avion Pharmaceuticals
$33
Boston Scientific Corporation
$31
REVANCE THERAPEUTICS, INC.
$30
ANI Pharmaceuticals, Inc.
$29
Scilex Pharmaceuticals Inc.
$28
Janssen Pharmaceuticals, Inc
$23
TG Therapeutics, Inc.
$22
Ipsen Biopharmaceuticals, Inc
$17
Almatica Pharma LLC
$17
Celgene Corporation
$16
SERVIER PHARMACEUTICALS LLC
$15
Top 3 companies account for 23.7% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AGAMREE · AMYVID · AVEIR · Adlarity · Apokyn · Austedo XR · BOTOX · BRILINTA · BRIUMVI · Briviact · DAXXIFY · DUOPA · Dhivy · Dysport · EPIDIOLEX · Evrysdi · FIRDAPSE · FYCOMPA · Fintepla · GAMMAGARD · GAMMAGARD LIQUID · GIVLAARI · GRALISE · HYQVIA · Hizentra · IDHIFA · INBRIJA · INGREZZA · JOT DX · KISUNLA · LYVISPAH · Leqembi · MAVENCLAD · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · Ocrevus · Ocrevus Zunovo · PANZYGA · PURIFIED CORTROPHIN GEL · QULIPTA · RADICAVA · RYTARY · SOLIRIS · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · WATCHMAN FLX · XARELTO · Xeomin · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a dermatology specialist in Boca Raton?
Compare dermatologists in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists in nearby ZIP areas
184
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
BOCA RATON REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bayas is a dermatology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Bayas receive payments from pharmaceutical companies?
Yes. Dr. Bayas received a total of $12,641 from 53 companies across 370 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Bayas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →